3 ASX All Ords shares with 'potential for strong future performance'

Tamim Asset Management reveals 3 ASX All Ords shares that are primed for growth.

| More on:
Boys making faces and flexing.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

S&P/ASX All Ordinaries (ASX: XAO) shares are up 0.58% to 8,606.1 points at the time of writing on Thursday.

Meantime, Tamim Asset Management has issued a note on three ASX All Ords shares to buy.

The broker says these stocks offer ASX investors an opportunity to capitalise on sector trends as well as company-specific growth drivers.

In an article, Tamim says these three companies share common themes of "resilience and the potential for strong future performance".

Let's check them out.

3 ASX All Ords shares primed for growth

Humm Group (ASX: HUM)

The Humm share price is 82 cents on Thursday, down 1.20% for the day and up 82% over the past 12 months.

Tamim said Humm had a difficult year but was showing signs of recovery.

The broker said the financial services company had positioned itself for future growth through cost-cutting measures and expansion of its commercial portfolio.

Tamim noted that Humm reported a normalised annual cash profit of $60.6 million, reflecting a 19% decrease from the prior year. This was largely due to the impact of rising interest rates, economic uncertainty and increased competition in the buy now, pay later sector.

Humm is expanding its commercial portfolio, which Tamim says has strong growth potential:

Humm could present an intriguing opportunity for investors who are willing to look beyond its recent challenges and focus on its long-term growth potential.

Praemium Ltd (ASX: PPS)

The Praemium share price is currently trading at 56.5 cents, down 1.74% today and up almost 1% over the past 12 months.

Tamim says Praemium's scalable business model, strong revenue growth, and product innovation make it a compelling investment opportunity in the technology arena.

The broker said Praemium delivered solid financial results for the year, with EBITDA of $21.5 million. This was driven by a particularly strong second-half performance. Tamim commented:

This growth was underpinned by Praemium's investment in capability, resilience, and IT security during the first half, which laid the groundwork for its subsequent financial success.

Tamim regards Praemium's acquisition of the OneView business from Iress Ltd (ASX: IRE) as a great strategic decision. The broker says it has enhanced the company's revenue, as well as its market profile.

The asset manager commented:

Looking ahead, Praemium's growth prospects appear strong. The company has identified a gap in the market for next-generation IDPs (Investment Data Platforms), which it is poised to address with its new offerings. This product innovation is expected to drive further revenue growth and expand Praemium's customer base to address the non custodial market for high net worth investors.

Australian Clinical Labs Ltd (ASX: ACL)

This ASX All Ords health care share is trading at $3.69, down 0.27% on Thursday and up 34% over the past 12 months.

Tamim noted a solid start to FY25 for Australian Clinical Labs, including improving margins.

It says the ASX All Ords share is undervalued and an attractive opportunity in the health care sector.

The broker noted the pathology provider's solid financial results despite a significant decline in COVID-related revenue. Underlying EBIT came in at $62.6 million, in line with the company's FY24 guidance.

The second half of the year was especially strong, with underlying EBIT growing to $39.1 million, representing an 11% margin.

The company's ability to drive margin expansion in the second half of the year reflects the success of its cost control measures and its focus on operational efficiency.

ACL has carried this positive momentum into FY25, with strong growth already evident in the early months of the fiscal year.

Tamim said Australian Clinical Labs had a strong balance sheet, and the ASX All Ords share's dividend yield remained attractive.

Looking ahead, ACL appears poised for a re-rating, particularly if it continues to deliver strong financial results in FY25 where we estimate it is highly likely to upgrade guidance at the AGM or first half result.

Motley Fool contributor Bronwyn Allen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Praemium. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A view from the track behind a runner in the starting block.
Opinions

3 beginner-friendly ASX shares perfect for Aussie investors starting out in November

Here’s why I like the look of these ASX shares for beginners.

Read more »

A group of business people pump the air and cheer.
Mergers & Acquisitions

This ASX small-cap stock is exploding 75% on takeover news!

The takeover premium is large.

Read more »

Two brokers analysing stocks.
Broker Notes

Don't miss these changes to broker ratings on ASX shares

The verdicts are in.

Read more »

Happy man working on his laptop.
Share Market News

5 things to watch on the ASX 200 on Wednesday

Will the market return to form today? Let's find out.

Read more »

a young farmer stands back and admires his work in arranging bales of hay to form a house shape with two bales balancing against each other to form a roof, perched on bales tipped on their side in an abstract house shape on a freshly harvested paddock.
Best Shares

Top ASX shares to buy in November with the market near all-time highs

Our writers are still finding value in a record-breaking Australian share market.

Read more »

Fancy font saying top ten surrounded by gold leaf set against a dark background of glittering stars.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors endured another day of selling this Tuesday.

Read more »

Man raising both his arms in the air with a piggy bank on his lap, symbolising a record high.
52-Week Highs

12 non-bank ASX 200 shares smashing new 52-week highs today

Do you own any of these stocks at 52-week highs today?

Read more »

Man pointing at a blue rising share price graph.
Technology Shares

Guess which ASX 300 tech stock is already up 64% in November!

The ASX 300 tech stock is surging higher this month. But why?

Read more »